GlassScriptPhysician profile
Douglas C Dedelow
NPI 1861492993
$15,901.87
in general payments reported to CMS, 2019-2025
46 companies · $818 in 2025
The $818 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,771 · 2020: $1,960 · 2021: $924 · 2022: $2,447 · 2023: $592 · 2024: $388 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $7,101.88 | 2019 | |
| Stryker Corporation | $1,900.53 | 2022 | |
| Coloplast Corp | $1,670.05 | 2019-2025 | Altis, Saffron |
| Abbvie INC. | $994.93 | 2019-2023 | Lo Loestrin Fe |
| Intuitive Surgical, INC. | $916.67 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $235.82 | 2019-2025 | |
| Agile Therapeutics, INC. | $208.46 | 2021-2024 | Twirla |
| Exeltis, USA INC. | $192.79 | 2019-2025 | Slynd |
| Avion Pharmaceuticals | $187.79 | 2019-2023 | Divigel |
| Pfizer INC. | $183.18 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $178.96 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $177.68 | 2021-2025 | |
| Hologic Sales and Service, LLC | $170.86 | 2019-2025 | Novasure, Fluent Fluid Management System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $157.89 | 2021-2022 | |
| Roche Diagnostics Corporation | $135.70 | 2019-2020 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $119.90 | 2019-2023 | Summit Doppler |
| Astellas Pharma US INC | $108.63 | 2022-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $98.19 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $96.41 | 2019-2020 | |
| Ethicon US, LLC | $91.09 | 2021-2025 | Ethicon, Vistaseal, Dermabond Prineo |
| Organon LLC | $87.53 | 2021-2025 | Nexplanon |
| Exact Sciences Corporation | $87.22 | 2024-2025 | Cologuard Collection Kit |
| Caldera Medical, INC | $80.39 | 2025 | |
| Boston Scientific Corporation | $78.92 | 2019-2025 | Axonics |
| Smith+Nephew, INC. | $53.23 | 2019-2021 | |
| Organogenesis INC. | $52.35 | 2025 | Puraply Wound Matrix |
| Momentis Surgical INC. | $47.00 | 2022 | |
| Vertical Pharmaceuticals, LLC | $43.15 | 2019-2020 | |
| Davol INC. | $41.79 | 2025 | Arista |
| Mylan Pharmaceuticals INC. | $40.53 | 2021 | |
| Merck Sharp & Dohme LLC | $39.65 | 2020-2021 | |
| Mimedx Group, INC. | $32.95 | 2025 | |
| Aspira Women'S Health INC | $32.60 | 2019-2022 | |
| Medtronic, INC. | $28.88 | 2024 | Truclear |
| Meditrina | $28.17 | 2021-2025 | |
| Daiichi Sankyo INC. | $27.71 | 2019-2022 | |
| Duchesnay USA Incorporated | $27.20 | 2019-2020 | |
| Mycovia Pharmaceuticals, INC. | $25.67 | 2022-2023 | Vivjoa |
| Nevro Corp. | $21.94 | 2019 | |
| Corcept Therapeutics | $16.07 | 2019 | |
| Mallinckrodt Hospital Products INC. | $15.61 | 2020 | |
| Convatec INC. | $15.00 | 2022 | |
| Mallinckrodt Enterprises LLC | $13.89 | 2019 | |
| Lupin INC. | $13.73 | 2019 | |
| Allergan, INC. | $11.92 | 2019 | |
| Teleflex LLC | $11.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Dedelow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.